Population record
Saudi Arabia · 18 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia | “Publications per 100,000 patient contacts ranged from 3.65 in the USA to 0.40 in Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “The Economic Impact of Premarital Screening (PMS) of Sickle Cell Anemia on the Saudi Health System: A Cost Analysis Study. Background: In Saudi Arabia, the government has implemented compulsory premarital screening and consultations for high-risk and positive sickle cell results (traits = AS gene and disease = SS gene). A total of 300,000 cases were processed through this decision tree model.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “A hybrid approach to enhance HbA1c prediction accuracy while minimizing the number of associated predictors: A case-control study in Saudi Arabia. Saudi Arabia currently ranks seventh worldwide in terms of prevalence rate. Analyses were conducted in a case-control study in Saudi Arabia involving cases (patients with HbA1c levels ≥ 6.5) and controls with normal HbA1c levels (< 6.5). Medical records from 3,000 King Abdulaziz University Hospital patients containing demographic, lifestyle, and lipid profile data were used to develop the models. The proposed model helps healthcare providers identify patients at risk of T2D by monitoring fewer key predictors of HbA1c levels, enhancing early intervention strategies for managing diabetes in Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “To illustrate this point, we imputed the genotypes of over 43,000 individuals across 123 populations around the world and identified numerous populations where imputation accuracy paled in comparison to that of European-ancestry populations. For instance, the mean imputation r-squared (Rsq) for variants with minor allele frequencies between 1% and 5% in Saudi Arabians (n = 1,061), Vietnamese (n = 1,264), Thai (n = 2,435), and Papua New Guineans (n = 776) were 0.79, 0.78, 0.76, and 0.62, respectively, compared to 0.90-0.93 for comparable European populations matched in sample size and SNP array content.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Prevalence and Predictors of Diabetic Retinopathy in Saudi Arabia: Insights from a Systematic Review and Meta-Analysis. BACKGROUND: Diabetic retinopathy (DR) is one of the leading causes of blindness among diabetic patients, particularly in areas with an increase in diabetes epidemics, such as Saudi Arabia. Notwithstanding the significant public health implications, data on the prevalence and risk factors of DR in Saudi Arabia are few and scattered, limited to certain geographic areas. Our study objective is to conduct a systematic review of the literature and a meta-analysis of the prevalence and predictors for DR in Saudi Arabia, within both type 1 and type 2 diabetes. Any study related to the prevalence of diabetic retinopathy in T1DM or T2DM among adult patients aged ≥18 years that was conducted in Saudi Arabia was included. RESULTS: A total of 11 studies published between 2006 and 2019 met the inclusion criteria, with sample sizes ranging from 99 to over 50,000 participants. CONCLUSIONS: The high prevalence of DR in Saudi Arabia highlights the critical need for focused public health initiatives, especially among those with type 2 diabetes. The increasing prevalence of DR in Saudi Arabia requires careful consideration of healthcare policy and resource allocation, which is made possible by our results.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Phenotypic and Genotypic Characterization of Hereditary Angioedema in Saudi Arabia. Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disorder affecting roughly 1:50,000 individuals. Here we document the clinical and genetic findings of HAE patients from a single Saudi institution, which is a major referral center at the national level. No type III (normal C1-INH) patients were encountered in the clinic, suggesting that this subtype does not play a major role in HAE pathogenesis in Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Human immunodeficiency virus in Saudi Arabia: Current and future challenges. However, in the Middle East and North Africa (MENA), an estimated 83,000 individuals still acquired the virus, with 37,000 morbidities reported. The first incidence of acquired immunodeficiency syndrome (AIDS) from the Kingdom of Saudi Arabia (KSA) was reported in 1984.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Knowledge and Awareness of Glaucoma Among People Living in Taif City in the Western Region of Saudi Arabia. This research explored glaucoma awareness in Taif City, Saudi Arabia. Results This study included 1,000 participants.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia. Data on population based cut-off values, disease ranges for true positive cases, false positive rates, true positive rates, cut-off verification and comparisons with international cut-off ranges have not been done for Saudi Arabia. About 74 000 patient results were reviewed to establish cut-off ranges from DBS samples received from five different hospitals during 2013-2020.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes. Here, we conducted a retrospective study of HLA class I and class II homozygosity at allelic and haplotype levels in unrelated individuals genotyped from 2012 to 2016 in a tertiary hospital in the capital of Saudi Arabia. Among 5,000 individuals, 2,773 individuals meet inclusion criteria and were retrospectively analyzed for HLA-A, -B, -C-DRB1, and -DQB1 homozygosity at allelic and haplotype levels. We were able to identify 15 HLA-A, 20 HLA-B, 11 HLA-C, 13 HLA-DRB1, and five HLA-DQB1 homozygous alleles demonstrating a very low genetic diversity in the Saudi population. This study shows low diversity of both class I and II alleles and haplotypes in the Saudi population, which would have a significant impact on shaping the transplantation practices, transfusion-associated graft versus host disease prevention strategies, and host-pathogen interactions.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Outreach and diagnosis: Saudi Arabia's experience. The annual global survey reported 295 000 individuals with haemophilia, von Willebrand disease and other bleeding disorders in 113 countries.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Saudi Arabia has a higher than the worldwide prevalence of the disease, estimated to be 4.42/100,000 cases.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Cystic fibrosis knowledge and practice among primary care physicians in southwest region, Saudi Arabia. INTRODUCTION: Cystic fibrosis (CF) is a multisystem autosomal recessive disease that affects 1 in 4,000 newborns in the United States and has high mortality and morbidity.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study. The incidence of ML-DS was 48 per 100,000 compared to 0.6 per 100,000 for AML in non-DS children. The incidence and clinical characteristics of ML-DS in Saudi patients were comparable to other reports.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Expanded Newborn Screening Program in Saudi Arabia: Incidence of screened disorders. AIM: To address the implementation of the National Newborn Screening Program (NBS) in Saudi Arabia and stratify the incidence of the screened disorders. METHODS: A retrospective study conducted between 1 August 2005 and 31 December 2012, total of 775 000 newborns were screened from 139 hospitals distributed among all regions of Saudi Arabia. CONCLUSION: The article highlights the experience of the NBS Program in Saudi Arabia and providing data on specific regional incidences of all the screened disorders included in the programme; and showed that the incidence of these disorders is one of the highest reported so far world-wide.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. An absence of screening for coinfections was detected in 7.0-48.5% patients as per the group and the infectious agent; which represents an estimated proportion of 20 out of 1,000 patients with an undiagnosed coinfection.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia. About 400,000 children are born with severe hemoglobinopathies each year.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Four investigations were pursued: Search of the motif in 250 000 control region records across 8 databases, comparison of frequencies of T subhaplogroups (T1, T2b, T2c, T2e, T4, T(*)) across 11 diverse populations, creation of a phylogenic median-joining network from public T2e control region entries, and analysis of one Sephardic mitochondrial full genomic sequence with the motif. The ratio of sister subhaplogroups T2e to T2b was found to vary 40-fold across populations from a low in the British Isles to a high in Saudi Arabia with the ratio in Sephardim more similar to Saudi Arabia, Egypt, and Italy than to hosts Spain and Portugal.” | 0.95 | saudi_context_rules_v1 |